By Mill Chart
Last update: Nov 13, 2023
In this article we will dive into PROGYNY INC (NASDAQ:PGNY) as a possible candidate for growth investing. Investors should always do their own research, but we noticed PROGYNY INC showing up in our Louis Navellier growth screen, which makes it worth to investigate a bit more.
ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.
We assign a fundamental rating of 6 out of 10 to PGNY. PGNY was compared to 115 industry peers in the Health Care Providers & Services industry. PGNY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PGNY is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make PGNY suitable for growth investing!
Check the latest full fundamental report of PGNY for a complete fundamental analysis.
Our Lois Navellier screen will find you more ideas suited for growth investing.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
PROGYNY INC
NASDAQ:PGNY (4/18/2024, 7:13:59 PM)
Premarket: 31.77 -0.11 (-0.35%)31.88
-0.87 (-2.66%)
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of...
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...
Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wagering on mid-cap stocks can potentially unlock investment treasures typicall...
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...
Progyny (PGNY) approves $100 million share repurchase program funded by available cash balances.
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...
Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint